Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Quinine sulfate 300mg/5ml oral suspension
0504010Y0AABCBC
|
Quinine sulfate | Quinine sulfate | Infections | 47 |
|
Levamisole 50mg tablets
0505020L0AAABAB
|
Levamisole hydrochloride | Levamisole hydrochloride | Infections | 45 |
|
Pyrimethamine 25mg tablets
0504010N0AAAAAA
|
Pyrimethamine | Pyrimethamine | Infections | 45 |
|
Benzylpenicillin sodium 600mg inj vials
0501011J0AAABAB
|
Benzylpenicillin sodium (Penicillin G) | Benzylpenicillin sodium (Penicillin G) | Infections | 43 |
|
Ertapenem 1g powder for solution for infusion vials
0501022B0AAAAAA
|
Ertapenem sodium | Ertapenem sodium | Infections | 43 |
|
Ampicillin 250mg capsules
0501013E0AAAAAA
|
Ampicillin | Ampicillin | Infections | 42 |
|
Famvir 250mg tablets
0503021E0BBAAAA
|
Famvir | Famciclovir | Infections | 42 |
|
Augmentin 125/31 oral suspension
0501013K0BBAPAH
|
Augmentin | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 40 |
|
Ciproxin 250mg/5ml oral suspension
0501120L0BBAJBG
|
Ciproxin | Ciprofloxacin | Infections | 40 |
|
Albendazole 400mg chewable tablets
0505030A0AAABAB
|
Albendazole | Albendazole | Infections | 39 |
|
Diflucan 50mg capsules
0502010B0BBAAAA
|
Diflucan | Fluconazole | Infections | 38 |
|
Rifinah 150mg/100mg tablets
0501090S0BBAAAA
|
Rifinah | Rifampicin combined preparations | Infections | 37 |
|
Distaclor MR 375mg tablets
0501021A0BBAEAG
|
Distaclor | Cefaclor | Infections | 35 |
|
Ovex 100mg chewable tablets
0505010D0BCAAAD
|
Ovex | Mebendazole | Infections | 35 |
|
Doxycycline 50mg/5ml oral solution
0501030I0AAAHAH
|
Doxycycline hyclate (Antibacterial) | Doxycycline hyclate | Infections | 34 |
|
Ketoconazole 200mg tablets
0502020A0AAACAC
|
Ketoconazole (Systemic) | Ketoconazole | Infections | 34 |
|
Neomycin 500mg tablets
0501040N0AAADAD
|
Neomycin sulfate (Systemic) | Neomycin sulfate | Infections | 32 |
|
Sporanox-Pulse 100mg capsules
0502010C0BBABAA
|
Sporanox | Itraconazole | Infections | 32 |
|
Tobramycin 300mg/4ml nebuliser liquid ampoules
0501040U0AAAKAK
|
Tobramycin (Systemic) | Tobramycin | Infections | 32 |
|
Augmentin-Duo 400/57 oral suspension
0501013K0BBAQAP
|
Augmentin | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 30 |
|
Azithromycin 200mg/5ml oral suspension sugar free
0501050A0AAAHAH
|
Azithromycin | Azithromycin | Infections | 30 |
|
Ivermectin 6mg tablets
0505060I0AAAEAE
|
Ivermectin | Ivermectin | Infections | 30 |
|
Ovex 100mg/5ml oral suspension
0505010D0BCABAA
|
Ovex | Mebendazole | Infections | 30 |
|
Amoxicillin 125mg/1.25ml oral suspension paediatric
0501013B0AAAIAI
|
Amoxicillin | Amoxicillin | Infections | 29 |
|
Malarone Paediatric 62.5mg/25mg tablets
0504010U0BBABAB
|
Malarone | Proguanil hydrochloride with atovaquone | Infections | 29 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.